Krendyukov, A., Kneisel, N., Zhu, J., Merz, C., Richards, D., Gieffers, C., . . . Mitchell, T. (2020). The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model. Elsevier.
Chicago Style (17th ed.) CitationKrendyukov, A., N. Kneisel, J. Zhu, C. Merz, D. Richards, C. Gieffers, B. Van Den Eynde, and T. Mitchell. The Role of Asunercept as a Selective CD95L Inhibitor in Cutaneous Melanoma: Rationale and Results from an Enhanced TiRP Model. Elsevier, 2020.
MLA引文Krendyukov, A., et al. The Role of Asunercept as a Selective CD95L Inhibitor in Cutaneous Melanoma: Rationale and Results from an Enhanced TiRP Model. Elsevier, 2020.
警告:這些引文格式不一定是100%准確.